Login / Signup

Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.

Yuezong BaiTong XieZhenghang WangShuang TongXiaochen ZhaoFeilong ZhaoJinping CaiXiaofan WeiZhi PengLin Shen
Published in: Journal for immunotherapy of cancer (2022)
mutation as potential predictive biomarkers of ICB efficacy in EBVaGC, which might better inform ICB treatment for EBVaGC.
Keyphrases
  • epstein barr virus
  • diffuse large b cell lymphoma
  • combination therapy
  • climate change
  • replacement therapy